longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

CAM INNODRUGS

03525

9.3052.36% ( -0.225 )
Delay Closed: Nov 16, 16:08:00
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends

Overview

CAM INNODRUGS (03525)

Open
9.305
High
9.305
Low
9.305
Prev. Close
9.530
Volume
0
Turnover
0
Avg Price
--
Bid/Ask Ratio
0.00%
Amplitude
0.00%
52wk High
10.520
Volume Ratio
0.00
Turnover Ratio
--
52wk Low
9.085
Dividend YieldTTM
--
DividendTTM
--
NAV
--
NAV Date
--
Disc/Prem Rate
--
Total Issued
0.00
Assets
--
Min lot size
100
Currency
HKD

News

  • PUBT · Nov 16, 2026 at 04:17 AM

    Akeso Says FDA Complete Response Letter May Explain Unusual Share Price Moves

  • Market Movers · Nov 16, 2026 at 01:30 AM

    Akeso plunges 25% as FDA declines ivonescimab U.S. approval

  • PUBT · Nov 16, 2026 at 06:17 AM

    Akeso's Gumokimab Wins China Approval for Active Ankylosing Spondylitis

  • TradingView · Nov 15, 2026 at 11:30 PM

    Ascentage Pharma Group International Secures NRDL Coverage for Two Drugs

  • AASTOCKS News · Nov 16, 2026 at 02:59 AM

    UBS: AKESO Partner Receives FDA Complete Response Letter for ivonescimab Plus Chemotherapy BLA, Slightly Negative

  • AASTOCKS News · Nov 16, 2026 at 04:27 AM

    Nomura Downgrades AKESO to Neutral, Cuts TP to HKD94

LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy